Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-08 Purchase |
2020-09-10 4:02 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | RAMSAY DAVID A Director |
1,000 | $3.83 | $3,830 | 48,000 (Direct) |
View |
| 2020-09-04 Purchase |
2020-09-09 6:55 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
278,369 | $3.9402 | $1,096,829 | 9,405,490 (Indirect) |
View |
| 2020-08-20 Purchase |
2020-08-24 4:22 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | RAMSAY DAVID A Director |
47,000 | $3.9884 | $187,456 | 47,000 (Direct) |
View |
| 2020-08-12 Purchase |
2020-08-14 4:49 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
431,647 | $3.7185 | $1,605,100 | 9,127,121 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-29 5:24 pm |
TETRAPHASE PHARMACEUTICALS INC | TTPH | LA JOLLA PHARMACEUTICAL CO 10% Owner |
3,737,360 | $2 | $7,474,720 | 4,822,360 (Indirect) |
View |
| 2020-06-19 Purchase |
2020-06-22 5:16 pm |
TETRAPHASE PHARMACEUTICALS INC | TTPH | LA JOLLA PHARMACEUTICAL CO 10% Owner |
234,698 | $2.6161 | $613,993 | 1,085,000 (Direct) |
View |
| 2020-06-02 Purchase |
2020-06-04 6:26 pm |
LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner |
615,129 | $4.9054 | $3,017,479 | 8,695,474 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-12 Option Award |
2021-02-18 4:24 pm |
N/A 2031-02-12 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
535 | $0 | 9,409,249 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-18 4:24 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
535 | $5.7035 | 9,409,249 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 5:21 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
118 | $5.202 | 9,408,297 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 5:21 pm |
N/A 2031-01-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
118 | $0 | 9,408,297 (Direct) |
View |
| 2021-01-15 Option Award(A) |
2021-02-02 5:20 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
136 | $4.5475 | 2,571 (Direct) |
View |
| 2020-12-31 Option Award(A) |
2021-02-02 5:18 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
1,648 | $3.298 | 4,083 (Direct) |
View |
| 2020-12-31 Option Award(A) |
2021-02-02 5:18 pm |
N/A 2030-12-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
1,648 | $0 | 4,083 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:57 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
136 | $4.5475 | 9,406,720 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:57 pm |
N/A 2031-01-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
136 | $0 | 9,406,720 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:32 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
171 | $3.298 | 9,406,619 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:32 pm |
N/A 2030-12-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
171 | $0 | 9,406,619 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 4:22 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
147 | $3.825 | 9,406,424 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-16 4:22 pm |
N/A 2030-12-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
147 | $0 | 9,406,424 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-14 9:55 pm |
N/A 2030-12-10 |
LA JOLLA PHARMACEUTICAL CO | LJPC | RAMSAY DAVID A Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-14 4:24 pm |
N/A 2030-12-10 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
52,191 | $0 | 52,191 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-14 4:23 pm |
N/A 2030-12-10 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer |
278,350 | $0 | 278,350 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-14 4:21 pm |
N/A 2030-12-10 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rosen Robert Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-14 4:20 pm |
N/A 2030-12-10 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Johnson Craig A Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-14 4:18 pm |
N/A 2030-12-10 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Johnson Laura L. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:21 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
134 | $4.225 | 9,406,264 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:21 pm |
N/A 2030-11-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
134 | $0 | 9,406,264 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:13 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
141 | $3.978 | 9,406,137 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:13 pm |
N/A 2030-11-13 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
141 | $0 | 9,406,137 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-05 4:59 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
196 | $2.89 | 9,406,051 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-05 4:59 pm |
N/A 2030-10-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
196 | $0 | 9,406,051 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 9:14 pm |
N/A 2030-10-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
169 | $0 | 9,405,828 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 9:14 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
169 | $3.32 | 9,405,828 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 4:57 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
286 | $3.85 | 73,733 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 4:57 pm |
N/A 2030-09-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
60,286 | $0 | 73,733 (Direct) |
View |
| 2020-08-31 Option Award |
2020-09-02 4:17 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
550 | $3.57 | 13,711 (Direct) |
View |
| 2020-08-31 Option Award |
2020-09-02 4:17 pm |
N/A 2030-08-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
550 | $0 | 13,711 (Direct) |
View |
| 2020-08-14 Option Award |
2020-08-18 5:18 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
589 | $3.34 | 13,200 (Direct) |
View |
| 2020-08-14 Option Award |
2020-08-18 5:18 pm |
N/A 2030-08-14 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
589 | $0 | 13,200 (Direct) |
View |
Ownership |
2020-08-07 8:19 pm |
N/A 2030-07-28 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer |
0 | $0 | 400,000 (Direct) |
View |
| 2020-07-31 Option Award |
2020-08-04 5:24 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
581 | $3.38 | 12,603 (Direct) |
View |
| 2020-07-31 Option Award |
2020-08-04 5:24 pm |
N/A 2030-07-31 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
581 | $0 | 12,603 (Direct) |
View |
| 2020-07-15 Option Award |
2020-07-17 4:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
521 | $3.77 | 11,962 (Direct) |
View |
| 2020-07-15 Option Award |
2020-07-17 4:05 pm |
N/A 2030-07-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
521 | $0 | 11,962 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 7:08 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
543 | $3.62 | 11,463 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 7:08 pm |
N/A 2030-06-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
543 | $0 | 11,463 (Direct) |
View |
Ownership |
2020-06-22 5:13 pm |
N/A N/A |
TETRAPHASE PHARMACEUTICALS INC | TTPH | LA JOLLA PHARMACEUTICAL CO 10% Owner |
0 | $0 | 850,302 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 6:26 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
435 | $4.51 | 10,812 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-17 6:26 pm |
N/A 2030-06-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
435 | $0 | 10,812 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-03 4:05 pm |
N/A 2030-06-01 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:03 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS Chief Financial Officer |
82 | $4.01 | 5,149 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:03 pm |
N/A 2030-05-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS Chief Financial Officer |
82 | $0 | 5,149 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:02 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
491 | $4.01 | 10,433 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:02 pm |
N/A 2030-05-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
491 | $0 | 10,433 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:02 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
205 | $4.01 | 81,976 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:02 pm |
N/A 2030-05-29 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
205 | $0 | 81,976 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 4:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS Chief Financial Officer |
56 | $5.86 | 5,041 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 4:05 pm |
N/A 2030-05-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS Chief Financial Officer |
56 | $0 | 5,041 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 4:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
335 | $5.86 | 9,786 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 4:05 pm |
N/A 2030-05-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
335 | $0 | 9,786 (Direct) |
View |